Dermata Therapeutics, Inc.
DRMA
$1.21
-$0.02-1.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.37M | -7.10M | -7.56M | -8.85M | -10.33M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 152.40K | 149.80K | 143.70K | 144.00K | 127.20K |
| Change in Net Operating Assets | 182.00K | -1.35M | -342.80K | -638.50K | -755.60K |
| Cash from Operations | -8.03M | -8.30M | -7.76M | -9.34M | -10.96M |
| Capital Expenditure | -110.70K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -110.70K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.18M | 6.18M | 12.73M | 8.54M | 13.09M |
| Repurchase of Common Stock | -13.30K | -560.90K | -560.90K | -629.50K | -616.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -91.40K | -91.40K | -50.50K | -50.50K | 19.50K |
| Cash from Financing | 6.08M | 5.53M | 12.12M | 7.86M | 12.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.07M | -2.77M | 4.36M | -1.48M | 1.53M |